FIELD: bioengineering.
SUBSTANCE: claimed invention discloses an isolated antibody or its fragment related to human Axl and described by the sequences of hyper variable sections CDR. Besides, it discloses a nucleic acid, a host cell and the production of the antibody or its fragment. Also, it presents an immunoconjugate including the antibody or its fragment and a cytotoxic agent. And, a pharmaceutical composition for aiming at the pathological states related with the expression and/or activity of the signal transmission cascades Axl. The application of the antibody or its fragment is described for the production of preparations for the treatment of malignant growth and for the inhibition of constitutive activation Axl.
EFFECT: application in the therapy of Axl-related diseases.
18 cl, 12 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
ANTIBODIES AGAINST NEYROPILIN AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2571226C2 |
HUMANIZED ANTIBODIES AND ANTIBODIES WITH MATURE AFFINITY AGAINST FcRH5 AND METHODS FOR THEIR APPLICATION | 2016 |
|
RU2748943C2 |
H7N9 INFLUENZA A THERAPY | 2015 |
|
RU2682049C2 |
ANTIBODIES TO JAGGED AND METHODS OF THEIR USE | 2013 |
|
RU2666990C2 |
PD1 ANTIBODIES AND THEIR APPLICATION METHODS | 2016 |
|
RU2746409C1 |
ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF | 2009 |
|
RU2580029C2 |
ANTIBODIES AGAINST FGFR3 AND METHODS OF THEIR APPLICATION | 2010 |
|
RU2568066C2 |
Authors
Dates
2016-03-20—Published
2011-06-17—Filed